摘要:
The present invention concerns an universal polypeptidic carrier for targeting directly or indirectly a molecule to Gb3 receptor expressing cells and having the following formula STxB-Z(n)-Cys, wherein: STxB is the Shiga Toxin B subunit or a functional equivalent thereof, Z is an amino-acid devoided of sulfydryl group, n being 0, 1 or a polypeptide, Cys is the amino-acid Cysteine. p
摘要:
The present invention concerns an universal polypeptidic carrier for targeting directly or indirectly a molecule to Gb3 receptor expressing cells and having the following formula STxB-Z(n)-Cys, wherein: STxB is the Shiga Toxin B subunit or a functional equivalent thereof, Z is an amino-acid devoided of sulfydryl group, n being 0, 1 or a polypeptide, Cys is the amino-acid Cysteine. p
摘要:
The invention concerns a polypeptide sequence comprising the fragment B of Shiga toxin or a functional equivalent thereof bound at the carboxy-terminal end with one or several polypeptides corresponding to the formula B - X in which B represents the fragment B of the Shiga toxin and X represents one or several polypeptides of therapeutic interest, and its use as active principle in a therapeutic composition.
摘要:
The present invention relates to a method of processing data for comparing at least two images using data processing means. A first sample of coordinate values (X 1 ,...,X n1 ) is extracted (100) from at least one first image (Im1) and a second sample of coordinate values (Y 1 ,...,Y n2 ) is extracted (100) from at least one second image (Im2). A normal score value (Z) is then computed (200), with the processing means, based on a density test statistic function ( T ) applied on the first and second samples of coordinate values, wherein this density test statistic function has an asymptotic distribution, and a p-value, derived from the computed normal score value (Z), is compared (400) with a predetermined level of significance (α) in order to determine a similarity between the two images. Such a method can be used for example for determining the influence of a compound on a biological structure, monitoring a drug treatment comprising one or more specific treatment compound(s), assessing the cytotoxicity of a predetermined compound on a biological structure, determining cellular morphology changes due to modifications in the expression level of cellular constituents, determining the influence of a infection by pathogens or detecting morphological changes in a biological structure over time.
摘要:
The invention concerns a polypeptide sequence comprising the fragment B of Shiga toxin or a functional equivalent thereof bound at the carboxy-terminal end with one or several polypeptides corresponding to the formula B - X in which B represents the fragment B of the Shiga toxin and X represents one or several polypeptides of therapeutic interest, and its use as active principle in a therapeutic composition.